Arginase and ornithine, as markers in human non-small cell lung carcinoma

Cancer Biochemistry Biophysics

Volumn 17, Issue 1-2, 1999, Pages 125-131

  Suer Gokmen S ^a   Yoruk Y ^a   Cakir E ^a   Yorulmaz, F ^a   Gulen S ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

Arginase; Human non small cell lung carcinoma; Ornithine

Indexed keywords

ARGINASE; ORNITHINE; TUMOR MARKER; TUMOR PROTEIN;

ADENOCARCINOMA; AGED; ARTICLE; CHEMISTRY; ENZYMOLOGY; HUMAN; LUNG; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MIDDLE AGED; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; AGED; ARGINASE; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; HUMANS; LUNG; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM PROTEINS; ORNITHINE; TUMOR MARKERS, BIOLOGICAL;

EID: 2142781800     PISSN: 03057232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Berueter, J., J.P. Colombo and C Bachmann (1978). Purification and properties of arginase from human liver and erythrocytes. Biochem. J. 175, 449-454.
2. Chinard, F.P (1952). Photometric estimation of proline and ornithine. J. Biol. Chem. 199, 91-95.
3. Clifford, A., D. Morgan, S.H. Yuspa, A.P. Soler and S Gilmour (1995). Role of ornithine decarboxylase in epidermal tumorigenesis. Cancer Res. 55, 1680-1686.
4. Colombo, J.P. and L. Konarska (1984). Arginase. In: H.U. Bergmeyer (eds.) Methods of enzymatic analysis. Vol. IV. Basel, Weinheim, Deerfield Beach, Verlag Chemie, 285-294.
5. Currie, G.A. (1978). Activated macrophages kill tumor cells by releasing arginase. Nature 273, 758-759.
6. Geyer, J.W. and D. Dabich (1971). Rapid method for determination of arginase activity in tissue homogenates. Anal. Biochem. 39, 412-417.
7. Grol, M. and K. Schumacher (1983). Purification and biochemical characterization of human liver-derived inhibitory protein (LIP). J. Immunol. 130, 323-326.
8. Harris, B.E., T.P. Pretlow, E.L. Bradley, G.B. Whitehurst and G. Pretlow (1983). Arginase activity in prostatic tissue of patients with benign prostatic hyperplasia and prostatic carcinoma. Cancer Res. 43, 3008-3012.
9. Hebby, O (1981). Role of polyamines in the control of cell proliferation and differentiation. Differentiation 19, 1-20.
10. Huang, M.H., C.C. Yang and S R. Wang (1992). Inhibition of lymphocyte proliferation by liver arginase. Life Sci. 51, 1752-1730.
11. Janne, J., H. Pöso and A. Raine (1978). Polyamines in rapid growth and cancer. Biochem. Biophys. Acta 473, 241-293.
12. Konarska, L., T. Kolasa, P. Albrecht and A. Regula (1993a). Can arginase be a marker of the large bowel neoplasia? Acta Biochim. Pol. 40, 164-166.
13. Konarska, L., I. Widzynska, H. Zienkiewicz and K Sulek (1993b) Arginase activity alterations in peripheral blood lymphocytes in the human chronic lymphocytic leukemia. Acta Biochim. Pol. 40, 160-163.
14. Koza, R.A., L.C. Megosh, M. Palmieri and T.G O'Brien (1991). Constitutively elevated levels of ornithine and polyamines in mouse epidermal papillomas. Carcinogenesis 12, 1619-1625.
15. Lauharanta, J. and K Kapyaho (1983) Arginase activity and polyamine biosynthesis in psoriasis. Acta. Derm. Venereol. (Stockh). 63, 277-282.
16. Leu, S.Y. and S.R. Wang (1992). Clinical significance of arginase in colorectal cancer. Cancer 70, 733-736.
17. Lowry, O.H., N.J Rosebrough, A.L. Farr and R.J. Randall (1951). Protein measurement with the Folin phenol reagent J. Biol Chem. 193, 265-275.
18. Mendez, J.D. and M.A. Areola (1992). Effect of L-arginine on pancreatic arginase activity and polyamines in alloxan-treated rats. Biochem. Int. 28, 569-575.
19. Pegg A.E. (1986). Recent advances in the biochemistry of polyamines in eukaryotes. Biochem. J. 234, 249-262.
20. Pegg, A.E. and P.P. McCann (1982). Polyamine metabolism and function. Am. J. Physiol. 243, C212-221.
21. Remesar, X., L.I. Arola, A. Palou and M. Alemany (1984) Arginase activitiy during pregnancy and lactation. Horm. Metab. Res. 16, 468-470.
22. Scalabrino, G. and M.E. Ferioli (1981). Polyamines in mammalian tumors. Part 1. Adv. Cancer. Res. 35, 151-268.
23. Spector, E.B., S.C.H. Rice, S. Moedjono, B. Bernard and C.D. Cederbaum (1982). Biochemical properties of arginase in human adult and fetal tissues. Biochem. Med. 28, 165-175.
24. Straus, B and O. Borcic (1976). Inhibitory action of some aminoacids on arginase from human liver, kidney, mammary gland and erythrocytes. Acta. Pharm. Jugosl. 26, 149-153
25. Straus, B., I. Cepelak and G. Festa (1992). Arginase, a new marker of mammary carcinoma. Clin. Chim. Acta 210, 5-12.
26. Tutton, P.J.M. and D.H. Barkla (1986) Comparison of the effects of an ornithine decarboxylase inhibitor on the intestinal epithelium and on intestinal tumor. Cancer Res. 46, 6091-6094.
27. Verma, A.K. and R.K. Boutwell (1981). Characterization of arginase activity from mouse epidermis and its relation to ornithine decarboxylase induction by the tumor promoting agent, 12-o-tetradecanoylphorbol-13-acetate. Biochim. Biophys. Acta 677, 184-189.
28. Wu, C.W., C.W. Chi, C.K. Ho, S.L. Chien, W.Y. Lui and F.K. P'eng (1994a). Effect of arginase on splenic killer cell activity in patients with gastric cancer. Dig. Dis. Sci. 39, 1107-1112.
29. Wu, C.W., C.W. Chi, E.C. Lin, W.Y. Lui, F.K. Peng and S.R. Wang (1994b). Serum arginase level in patients with gastric cancer. J. Clin. Gastroenterol. 18, 84-85.
30. Wu, C.W., C.W. Chi, S. H. Tsay, W.Y. Lui, F.K. P'eng, K.L. Chang, M.H. Huang and S.R. Wang (1987). The effects of arginase on neoplasm. I. The role of arginase in the immunosuppressive effects of extract from gastric cancer. Chin. J. Microbiol. Immunol. 20, 279-289.
31. Wu, C.W., S.R. Wang, T.J. Chang, E.C. Lin, K.L. Chang, M.H. Huang, W.Y. Lui, F.K. P'eng and C.W. Chi (1989). Content of glucocorticoid receptor and arginase in gastric cancer and normal mucosal tissues. Cancer 64, 2552-2556.
32. Yamanaka, H., T. Mayuzumi, M. Matsuoka, J. Shimazaki and K. Shida (1972). Arginase in human urogenital tumors. Gann 63, 693-700.
33. Zamecka, E. and Z. Porembska (1988). Five forms of arginase in human tissues. Biochem. Med. Metab. Biol. 39, 258-266.